[Dermatofibrosarcoma protuberans. About 18 cases]

I Zaraa1, E Cherif, L Ferchichi

  • 1Service de dermatologie, Hôpital La Rabta, Tunis.

La Tunisie Medicale
|December 24, 2005
PubMed

Insights

Dermatofibrosarcoma protuberans (DFSP) is a rare skin tumor. Surgical excision is crucial for managing this intermediate malignancy to minimize recurrence risk.

Area of Science:

  • Dermatology
  • Oncology
  • Pathology

Background:

  • Dermatofibrosarcoma protuberans (DFSP) is a rare, slow-growing cutaneous mesenchymal tumor.
  • DFSP exhibits a high recurrence rate but limited metastatic potential.
  • Understanding DFSP epidemiology and treatment is vital for patient outcomes.

Observation:

  • A retrospective study analyzed 18 DFSP cases over 16 years.
  • The mean patient age was 32 years, with a 1.57 male-to-female ratio.
  • The trunk was the most common site (77.5%), and CD34 positivity was observed in 14 cases.

Findings:

  • Histological features were typical in all DFSP cases.
  • Surgical treatment was performed in 13 out of 18 cases.
  • DFSP is an intermediate malignancy with potential for aggressive behavior.

Implications:

  • Wide surgical excision is the recommended treatment for DFSP.
  • Effective management strategies are essential to reduce DFSP recurrence.
  • Further research into DFSP can improve therapeutic approaches.